Annals of Surgical Oncology, Vol 7, Issue 3 188-192, Copyright © 2000 by Society of Surgical Oncology

ARTICLES

Should internal mammary nodes be sampled in the sentinel lymph node era?

S. L. Sugg, D. J. Ferguson, M. C. Posner and R. Heimann
Department of Surgery, University of Chicago, Illinois, USA.

BACKGROUND: Controversy exists regarding internal mammary lymph nodes (IMNs) in the staging and treatment of breast cancer. Sentinel lymph node identification with radiocolloid can map drainage to IMNs and directed biopsy can be performed with minimal morbidity. Furthermore, recent studies suggest that IMN drainage of breast tumors may be underestimated. To gain further insight into the prognostic value of IMNs, we reviewed the outcome of patients in whom the IMN status was routinely assessed. METHODS: A retrospective review of 286 patients with breast cancer who underwent IMN dissection between 1956 and 1987 was conducted. RESULTS: Median follow-up is 186 months, age was 52 years (range, 21-85 years), tumor size was 2.5 cm, and number of IMNs removed was 5 (range, 1-22); 44% received chemotherapy, 16% endocrine therapy, and 5% radiotherapy. Presence of IMN metastases correlated with primary tumor size (P < .0001) and number of positive axillary nodes (P < .0001) but did not correlate with primary tumor location or age. Overall, the 20-year disease-free survival is significantly worse for the 25% of patients with IMN metastases (P < .0001). In patients with positive axillary nodes and tumors smaller than 2 cm, there was a significantly worse survival (P < .0001) in the patients with IMN metastases. This difference in survival was not seen in women with tumors larger than 2 cm. CONCLUSIONS: Patients with IMN metastases, regardless of axillary node status, have a highly significant decrease in 20-year disease-free survival. Treatment strategies based on knowledge of sentinel IMN status may lead to improvement in survival, especially for patients with small tumors. At present, sentinel IMN biopsies should be performed in a clinical trial setting.

This article has been cited by other articles:

				F. L. Greene and L. H. Sobin The Staging of Cancer: A Retrospective and Prospective Appraisal CA Cancer J Clin, May 1, 2008; 58(3): 180 - 190. [Abstract] [Full Text] [PDF]

				M. S. Yao, B. F. Kurland, A. H. Smith, E. K. Schubert, L. K. Dunnwald, D. R. Byrd, and D. A. Mankoff Internal Mammary Nodal Chain Drainage Is a Prognostic Indicator in Axillary Node-Positive Breast Cancer Ann. Surg. Oncol., October 1, 2007; 14(10): 2985 - 2993. [Abstract] [Full Text] [PDF]

				P Veit-Haibach, G Antoch, T Beyer, H Stergar, R Schleucher, E A M Hauth, and A Bockisch FDG-PET/CT in restaging of patients with recurrent breast cancer: possible impact on staging and therapy Br. J. Radiol., July 1, 2007; 80(955): 508 - 515. [Abstract] [Full Text] [PDF]

				M. Cengiz Internal Mammary Lymphatic Irradiation: To Be or Not to Be? J. Clin. Oncol., June 1, 2004; 22(11): 2257 - 2258. [Full Text] [PDF]

				S. H. Estourgie, P. J. Tanis, O. E. Nieweg, R. A. Valdes Olmos, E. J. Th. Rutgers, and B. B. R. Kroon Should the Hunt for Internal Mammary Chain Sentinel Nodes Begin? An Evaluation of 150 Breast Cancer Patients Ann. Surg. Oncol., October 1, 2003; 10(8): 935 - 941. [Abstract] [Full Text] [PDF]

				W. B. Eubank, D. A. Mankoff, H. J. Vesselle, J. F. Eary, E. K. Schubert, L. K. Dunnwald, S. K. Lindsley, J. R. Gralow, M. M. Austin-Seymour, G. K. Ellis, et al. Detection of Locoregional and Distant Recurrences in Breast Cancer Patients by Using FDG PET RadioGraphics, January 1, 2002; 22(1): 5 - 17. [Abstract] [Full Text] [PDF]

				E. Dupont, C. E. Cox, K. Nguyen, C. J. Salud, E. S. Peltz, G. F. Whitehead, M. D. Ebert, N. Ni Ku, and D. S. Reintgen Utility of Internal Mammary Lymph Node Removal When Noted by Intraoperative Gamma Probe Detection Ann. Surg. Oncol., December 1, 2001; 8(10): 833 - 836. [Abstract] [Full Text] [PDF]

				W. B. Eubank, D. A. Mankoff, J. Takasugi, H. Vesselle, J. F. Eary, T. J. Shanley, J. R. Gralow, A. Charlop, G. K. Ellis, K. L. Lindsley, et al. 18Fluorodeoxyglucose Positron Emission Tomography to Detect Mediastinal or Internal Mammary Metastases in Breast Cancer J. Clin. Oncol., August 1, 2001; 19(15): 3516 - 3523. [Abstract] [Full Text] [PDF]

				G. Mariani, L. Moresco, G. Viale, G. Villa, M. Bagnasco, G. Canavese, J. Buscombe, H. W. Strauss, and G. Paganelli Radioguided Sentinel Lymph Node Biopsy in Breast Cancer Surgery J. Nucl. Med., August 1, 2001; 42(8): 1198 - 1215. [Abstract] [Full Text] [PDF]

				R. L. Birdwell, K. L. Smith, B. J. Betts, D. M. Ikeda, H. W. Strauss, and S. S. Jeffrey Breast Cancer: Variables Affecting Sentinel Lymph Node Visualization at Preoperative Lymphoscintigraphy Radiology, July 1, 2001; 220(1): 47 - 53. [Abstract] [Full Text] [PDF]

				D. R. Byrd, L. K. Dunnwald, D. A. Mankoff, B. O. Anderson, R. E. Moe, R. S. Yeung, E. K. Schubert, and J. F. Eary Internal Mammary Lymph Node Drainage Patterns in Patients With Breast Cancer Documented by Breast Lymphoscintigraphy Ann. Surg. Oncol., April 1, 2001; 8(3): 234 - 240. [Abstract] [Full Text] [PDF]